AquaBounty Technologies Stock (NASDAQ: AQB) stock price, news, charts, stock research, profile.
Day Range- - - | 52 Wk Range0.582 - 2.370 | Open / Close- / - | Float / Outstanding70.646M / 71.111M |
Vol / Avg.0 / 297.672K | Mkt Cap83.200M | P/E- | 50d Avg. Price0.790 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float70.646M | EPS-0.310 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-09 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.090 | -0.080 | 0.0100 | ||||
REV | 1.040M | 653.432K | -386.568K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of AquaBounty Technologies (NASDAQ: AQB) through any online brokerage.
Other companies in AquaBounty Technologies’s space includes: Impel Pharmaceuticals (NASDAQ:IMPL), Ambrx Biopharma (NYSE:AMAM), Aligos Therapeutics (NASDAQ:ALGS), NuCana (NASDAQ:NCNA) and Portage Biotech (NASDAQ:PRTG).
The latest price target for AquaBounty Technologies (NASDAQ: AQB) was reported by HC Wainwright & Co. on Tuesday, November 9, 2021. The analyst firm set a price target for 0.00 expecting AQB to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for AquaBounty Technologies (NASDAQ: AQB) is $1.17 last updated January 31, 2023 at 9:00 PM UTC.
There are no upcoming dividends for AquaBounty Technologies.
AquaBounty Technologies’s Q4 earnings are confirmed for Thursday, March 9, 2023.
There is no upcoming split for AquaBounty Technologies.
AquaBounty Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
AquaBounty Technologies Stock (NASDAQ: AQB) stock price, news, charts, stock research, profile.
Day Range- - - | 52 Wk Range0.582 - 2.370 | Open / Close- / - | Float / Outstanding70.646M / 71.111M |
Vol / Avg.0 / 297.672K | Mkt Cap83.200M | P/E- | 50d Avg. Price0.790 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float70.646M | EPS-0.310 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-09 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.090 | -0.080 | 0.0100 | ||||
REV | 1.040M | 653.432K | -386.568K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of AquaBounty Technologies (NASDAQ: AQB) through any online brokerage.
Other companies in AquaBounty Technologies’s space includes: Impel Pharmaceuticals (NASDAQ:IMPL), Ambrx Biopharma (NYSE:AMAM), Aligos Therapeutics (NASDAQ:ALGS), NuCana (NASDAQ:NCNA) and Portage Biotech (NASDAQ:PRTG).
The latest price target for AquaBounty Technologies (NASDAQ: AQB) was reported by HC Wainwright & Co. on Tuesday, November 9, 2021. The analyst firm set a price target for 0.00 expecting AQB to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for AquaBounty Technologies (NASDAQ: AQB) is $1.17 last updated January 31, 2023 at 9:00 PM UTC.
There are no upcoming dividends for AquaBounty Technologies.
AquaBounty Technologies’s Q4 earnings are confirmed for Thursday, March 9, 2023.
There is no upcoming split for AquaBounty Technologies.
AquaBounty Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
AquaBounty Technologies Stock (NASDAQ: AQB) stock price, news, charts, stock research, profile.
Day Range- - - | 52 Wk Range0.582 - 2.370 | Open / Close- / - | Float / Outstanding70.646M / 71.111M |
Vol / Avg.0 / 297.672K | Mkt Cap83.200M | P/E- | 50d Avg. Price0.790 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float70.646M | EPS-0.310 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-09 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.090 | -0.080 | 0.0100 | ||||
REV | 1.040M | 653.432K | -386.568K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of AquaBounty Technologies (NASDAQ: AQB) through any online brokerage.
Other companies in AquaBounty Technologies’s space includes: Impel Pharmaceuticals (NASDAQ:IMPL), Ambrx Biopharma (NYSE:AMAM), Aligos Therapeutics (NASDAQ:ALGS), NuCana (NASDAQ:NCNA) and Portage Biotech (NASDAQ:PRTG).
The latest price target for AquaBounty Technologies (NASDAQ: AQB) was reported by HC Wainwright & Co. on Tuesday, November 9, 2021. The analyst firm set a price target for 0.00 expecting AQB to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for AquaBounty Technologies (NASDAQ: AQB) is $1.17 last updated January 31, 2023 at 9:00 PM UTC.
There are no upcoming dividends for AquaBounty Technologies.
AquaBounty Technologies’s Q4 earnings are confirmed for Thursday, March 9, 2023.
There is no upcoming split for AquaBounty Technologies.
AquaBounty Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
AquaBounty Technologies Stock (NASDAQ: AQB) stock price, news, charts, stock research, profile.
Day Range- - - | 52 Wk Range0.582 - 2.370 | Open / Close- / - | Float / Outstanding70.646M / 71.111M |
Vol / Avg.0 / 297.672K | Mkt Cap83.200M | P/E- | 50d Avg. Price0.790 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float70.646M | EPS-0.310 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-09 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.090 | -0.080 | 0.0100 | ||||
REV | 1.040M | 653.432K | -386.568K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of AquaBounty Technologies (NASDAQ: AQB) through any online brokerage.
Other companies in AquaBounty Technologies’s space includes: Impel Pharmaceuticals (NASDAQ:IMPL), Ambrx Biopharma (NYSE:AMAM), Aligos Therapeutics (NASDAQ:ALGS), NuCana (NASDAQ:NCNA) and Portage Biotech (NASDAQ:PRTG).
The latest price target for AquaBounty Technologies (NASDAQ: AQB) was reported by HC Wainwright & Co. on Tuesday, November 9, 2021. The analyst firm set a price target for 0.00 expecting AQB to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for AquaBounty Technologies (NASDAQ: AQB) is $1.17 last updated January 31, 2023 at 9:00 PM UTC.
There are no upcoming dividends for AquaBounty Technologies.
AquaBounty Technologies’s Q4 earnings are confirmed for Thursday, March 9, 2023.
There is no upcoming split for AquaBounty Technologies.
AquaBounty Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
AquaBounty Technologies Stock (NASDAQ: AQB) stock price, news, charts, stock research, profile.
Day Range- - - | 52 Wk Range0.582 - 2.370 | Open / Close- / - | Float / Outstanding70.646M / 71.111M |
Vol / Avg.0 / 297.672K | Mkt Cap83.200M | P/E- | 50d Avg. Price0.790 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float70.646M | EPS-0.310 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-09 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.090 | -0.080 | 0.0100 | ||||
REV | 1.040M | 653.432K | -386.568K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of AquaBounty Technologies (NASDAQ: AQB) through any online brokerage.
Other companies in AquaBounty Technologies’s space includes: Impel Pharmaceuticals (NASDAQ:IMPL), Ambrx Biopharma (NYSE:AMAM), Aligos Therapeutics (NASDAQ:ALGS), NuCana (NASDAQ:NCNA) and Portage Biotech (NASDAQ:PRTG).
The latest price target for AquaBounty Technologies (NASDAQ: AQB) was reported by HC Wainwright & Co. on Tuesday, November 9, 2021. The analyst firm set a price target for 0.00 expecting AQB to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for AquaBounty Technologies (NASDAQ: AQB) is $1.17 last updated January 31, 2023 at 9:00 PM UTC.
There are no upcoming dividends for AquaBounty Technologies.
AquaBounty Technologies’s Q4 earnings are confirmed for Thursday, March 9, 2023.
There is no upcoming split for AquaBounty Technologies.
AquaBounty Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
AquaBounty Technologies Stock (NASDAQ: AQB) stock price, news, charts, stock research, profile.
Day Range- - - | 52 Wk Range0.582 - 2.370 | Open / Close- / - | Float / Outstanding70.646M / 71.111M |
Vol / Avg.0 / 297.672K | Mkt Cap83.200M | P/E- | 50d Avg. Price0.790 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float70.646M | EPS-0.310 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-09 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.090 | -0.080 | 0.0100 | ||||
REV | 1.040M | 653.432K | -386.568K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of AquaBounty Technologies (NASDAQ: AQB) through any online brokerage.
Other companies in AquaBounty Technologies’s space includes: Impel Pharmaceuticals (NASDAQ:IMPL), Ambrx Biopharma (NYSE:AMAM), Aligos Therapeutics (NASDAQ:ALGS), NuCana (NASDAQ:NCNA) and Portage Biotech (NASDAQ:PRTG).
The latest price target for AquaBounty Technologies (NASDAQ: AQB) was reported by HC Wainwright & Co. on Tuesday, November 9, 2021. The analyst firm set a price target for 0.00 expecting AQB to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for AquaBounty Technologies (NASDAQ: AQB) is $1.17 last updated January 31, 2023 at 9:00 PM UTC.
There are no upcoming dividends for AquaBounty Technologies.
AquaBounty Technologies’s Q4 earnings are confirmed for Thursday, March 9, 2023.
There is no upcoming split for AquaBounty Technologies.
AquaBounty Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
AquaBounty Technologies Stock (NASDAQ: AQB) stock price, news, charts, stock research, profile.
Day Range- - - | 52 Wk Range0.582 - 2.370 | Open / Close- / - | Float / Outstanding70.646M / 71.111M |
Vol / Avg.0 / 297.672K | Mkt Cap83.200M | P/E- | 50d Avg. Price0.790 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float70.646M | EPS-0.310 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-09 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.090 | -0.080 | 0.0100 | ||||
REV | 1.040M | 653.432K | -386.568K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of AquaBounty Technologies (NASDAQ: AQB) through any online brokerage.
Other companies in AquaBounty Technologies’s space includes: Impel Pharmaceuticals (NASDAQ:IMPL), Ambrx Biopharma (NYSE:AMAM), Aligos Therapeutics (NASDAQ:ALGS), NuCana (NASDAQ:NCNA) and Portage Biotech (NASDAQ:PRTG).
The latest price target for AquaBounty Technologies (NASDAQ: AQB) was reported by HC Wainwright & Co. on Tuesday, November 9, 2021. The analyst firm set a price target for 0.00 expecting AQB to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for AquaBounty Technologies (NASDAQ: AQB) is $1.17 last updated January 31, 2023 at 9:00 PM UTC.
There are no upcoming dividends for AquaBounty Technologies.
AquaBounty Technologies’s Q4 earnings are confirmed for Thursday, March 9, 2023.
There is no upcoming split for AquaBounty Technologies.
AquaBounty Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
AquaBounty Technologies Stock (NASDAQ: AQB) stock price, news, charts, stock research, profile.
Day Range- - - | 52 Wk Range0.582 - 2.370 | Open / Close- / - | Float / Outstanding70.646M / 71.111M |
Vol / Avg.0 / 297.672K | Mkt Cap83.200M | P/E- | 50d Avg. Price0.790 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float70.646M | EPS-0.310 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-09 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.090 | -0.080 | 0.0100 | ||||
REV | 1.040M | 653.432K | -386.568K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of AquaBounty Technologies (NASDAQ: AQB) through any online brokerage.
Other companies in AquaBounty Technologies’s space includes: Impel Pharmaceuticals (NASDAQ:IMPL), Ambrx Biopharma (NYSE:AMAM), Aligos Therapeutics (NASDAQ:ALGS), NuCana (NASDAQ:NCNA) and Portage Biotech (NASDAQ:PRTG).
The latest price target for AquaBounty Technologies (NASDAQ: AQB) was reported by HC Wainwright & Co. on Tuesday, November 9, 2021. The analyst firm set a price target for 0.00 expecting AQB to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for AquaBounty Technologies (NASDAQ: AQB) is $1.17 last updated January 31, 2023 at 9:00 PM UTC.
There are no upcoming dividends for AquaBounty Technologies.
AquaBounty Technologies’s Q4 earnings are confirmed for Thursday, March 9, 2023.
There is no upcoming split for AquaBounty Technologies.
AquaBounty Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
AquaBounty Technologies Stock (NASDAQ: AQB) stock price, news, charts, stock research, profile.
Day Range- - - | 52 Wk Range0.582 - 2.370 | Open / Close- / - | Float / Outstanding70.646M / 71.111M |
Vol / Avg.0 / 297.672K | Mkt Cap83.200M | P/E- | 50d Avg. Price0.790 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float70.646M | EPS-0.310 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-09 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.090 | -0.080 | 0.0100 | ||||
REV | 1.040M | 653.432K | -386.568K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of AquaBounty Technologies (NASDAQ: AQB) through any online brokerage.
Other companies in AquaBounty Technologies’s space includes: Impel Pharmaceuticals (NASDAQ:IMPL), Ambrx Biopharma (NYSE:AMAM), Aligos Therapeutics (NASDAQ:ALGS), NuCana (NASDAQ:NCNA) and Portage Biotech (NASDAQ:PRTG).
The latest price target for AquaBounty Technologies (NASDAQ: AQB) was reported by HC Wainwright & Co. on Tuesday, November 9, 2021. The analyst firm set a price target for 0.00 expecting AQB to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for AquaBounty Technologies (NASDAQ: AQB) is $1.17 last updated January 31, 2023 at 9:00 PM UTC.
There are no upcoming dividends for AquaBounty Technologies.
AquaBounty Technologies’s Q4 earnings are confirmed for Thursday, March 9, 2023.
There is no upcoming split for AquaBounty Technologies.
AquaBounty Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.